Search Results 641-650 of 17363 for Cyclophosphamide

  1. Stomach Cancer Clinical Trials - Mayo Clinic Research

    A Phase Ib/II, open label, multi-center, randomized study designed to assess the safety, tolerability, pharmacokinetics and preliminary anti-tumor activity of ...

  2. Clinical trials - Oncology (Medical)

    The purpose of this study is to evaluate whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or ...

  3. Oncology (Medical) - Clinical trials

    The purpose of this study is to determine the preliminary anti-tumor activity and confirm the safety of VV1 in combination with Cemiplimab.

  4. Trimethoprim-sulfamethoxazole Graded Administration in Oncology, Hematopoietic Stem Cell Transplant, and Solid Organ Transplant Patients with a History of Sulfonamide Allergy - Mayo Clinic

    Trimethoprim-sulfamethoxazole Graded Administration in Oncology, Hematopoietic Stem Cell Transplant, and Solid Organ Transplant Patients with a History of ...

  5. Cytotoxic Action of Novel Anti-Neoplastic Agents - Anticancer Drug Action Laboratory - Mayo Clinic Research

    Dr. Kaufmann and his team in the Anticancer Drug Action Lab at Mayo Clinic are studying the cytotoxic action of novel anti-neoplastic agents.

  6. Mayo Clinic in Florida offers rare procedure for cancer patients: Photodynamic stabilization of skeletal metastatic disease

    Metastases break through bones, requiring rapid treatment for patients who are ineligible for total joint arthroplasty. Mayo Clinic offers photodynamic ...

  7. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  8. Phase I Study of LB-100 With Docetaxel in Solid Tumors - Mayo Clinic

    LB-100 is a small molecule that in laboratory and animal studies has shown activity when used by itself or together with drugs approved to treat some types of ...

  9. Pilot Study of ACTH in the Treatment of IgA Nephropathy at High Risk of Progression - Mayo Clinic

    Patients who had received immunosuppressive therapy including cyclophosphamide, MMF, cyclosporine, tacrolimus or azathioprine in the last 6 months. Current ...

  10. The ExTINGUISH Trial Of Inebilizumab In NMDAR Encephalitis (ExTINGUISH) - Mayo Clinic

    Cyclophosphamide;; Azathioprine;; Mycophenolate mofetil. Severe drug allergic history or anaphylaxis to two or more food products or medicines (including ...